Neuro Aptamer

New Possibilities of Dementia therapeutics
(Alzheimer's disease)
NXP031 shows the therapeutics possibilities for degenerative brain disease.

A Game changer in dementia therapeutics

Oxidative stress and neuroinflammation are the most important causes of degenerative brain diseases such as Alzheimer's and Parkinson’s.
NXP03 has been shown to be effective in experimental animal models of various degenerative brain diseases.

NXP031 with aptamin C technology reduces oxidative stress, neuroinflammation and disease-causing toxic protein plaques (Amyloid-β, alpha-synuclein) in the brain to protect nerve cells